Search Results

Selective targeting of MYC mRNA by stabilized antisense oligonucleotides

• Authors : Gill, Taylor; Wang, Haichuan; Bandaru, Raj

Subjects: Biochemistry and Cell Biology; Biomedical and Clinical Sciences; Oncology and Carcinogenesis

• Source: Oncogene. 40(47)

Record details

Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.

• Authors : Matsubara, H.^1,2; Takeuchi, T.¹; Nishikawa, E.¹

• Source: Oncogene. 9/6/2007, Vol. 26 Issue 41, p6099-6105. 7p. 1 Black and White Photograph, 1 Diagram, 2 Graphs.

Record details

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

• Authors : Spankuch-Schmitt, Birgit; Wolf, Georg; Solbach, Christine

• Source: Oncogene. 5/9/2002, Vol. 21 Issue 20, p3162. 10p. 6 Color Photographs, 3 Diagrams, 14 Graphs.

Record details

Telomerase inhibition, oligonucleotides, and clinical trials.

• Authors : Corey, David R

• Source: Oncogene. 1/21/2002 Review, Vol. 21 Issue 4, p631. 7p.

Record details

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells

• Authors : Birgit, Spänkuch-Schmitt; Georg, Wolf; Christine, Solbach

Subjects: 0301 basic medicine; 0303 health sciences; Lung Neoplasms

• Source: Oncogene. 21:3162-3171

Record details

Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.

• Authors : Herbert, Brittney-Shea^1,2,3 ; Gellert, Ginelle C.¹; Hochreiter, Amelia^2,3

• Source: Oncogene. 8/4/2005, Vol. 24 Issue 33, p5262-5268. 7p.

Record details

RAF antisense oligonucleotide as a tumor radiosensitizer.

• Authors : Kasid, Usha¹; Dritschilo, Anatoly¹

• Source: Oncogene. 9/1/2003 Review, Vol. 22 Issue 37, p5876-5884. 9p.

Record details

Efficient in vivo microRNA targeting of liver metastasis.

• Authors : Huynh C; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Segura MF

Subjects: Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*secondary ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*therapy ; Melanoma/Melanoma/Melanoma/*secondary

• Source: Oncogene [Oncogene] 2011 Mar 24; Vol. 30 (12), pp. 1481-8. Date of Electronic Publication: 2010 Nov 22.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Antisense oligonucleotide-based therapeutics for cancer.

• Authors : Dean NM; ISIS Pharmaceuticals, 2282 Faraday Ave, Carlsbad, CA 92008, USA.; Bennett CF

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Oligonucleotides, Antisense/Oligonucleotides, Antisense/Oligonucleotides, Antisense/*pharmacology; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/chemistry

• Source: Oncogene [Oncogene] 2003 Dec 08; Vol. 22 (56), pp. 9087-96.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print Cited Medium: Print ISSN: 0950-9232

Record details

The dual role of helix – loop – helix-zipper protein USF in ribosomal RNA gene transcription in vivo.

• Authors : Ghosh, Asish K; Datta, Prasun K; Jacob, Samson T

• Source: Oncogene. 2/6/97, Vol. 14 Issue 5, p589. 6p.

Record details